Kennedy Capital Management’s Cogent Biosciences COGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.73M | Buy |
520,127
+38,886
| +8% | +$279K | 0.09% | 340 |
|
|
2025
Q1 | $2.88M | Buy |
481,241
+24,193
| +5% | +$145K | 0.07% | 376 |
|
|
2024
Q4 | $3.56M | Sell |
457,048
-5,140
| -1% | -$40.1K | 0.08% | 393 |
|
|
2024
Q3 | $4.99M | Buy |
462,188
+2,250
| +0.5% | +$24.3K | 0.11% | 319 |
|
|
2024
Q2 | $3.88M | Sell |
459,938
-245,693
| -35% | -$2.07M | 0.08% | 380 |
|
|
2024
Q1 | $4.74M | Buy |
705,631
+385,315
| +120% | +$2.59M | 0.1% | 334 |
|
|
2023
Q4 | $1.88M | Buy |
320,316
+53,782
| +20% | +$316K | 0.04% | 505 |
|
|
2023
Q3 | $2.6M | Sell |
266,534
-523
| -0.2% | -$5.1K | 0.06% | 414 |
|
|
2023
Q2 | $3.16M | Buy |
267,057
+78,310
| +41% | +$927K | 0.07% | 386 |
|
|
2023
Q1 | $2.04M | Buy |
188,747
+69,582
| +58% | +$751K | 0.06% | 401 |
|
|
2022
Q4 | $1.38M | Sell |
119,165
-1,883
| -2% | -$21.8K | 0.04% | 449 |
|
|
2022
Q3 | $1.81M | Buy |
+121,048
| New | +$1.81M | 0.05% | 432 |
|